Literature DB >> 12408678

Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells.

Yoshitaka Kumon1, Yuh Nakauchi, Tadashi Suehiro, Tomoko Shiinoki, Noriyasu Tanimoto, Mari Inoue, Toshihiro Nakamura, Kozo Hashimoto, Jean D Sipe.   

Abstract

The expression of paraoxonase1 (PON1) during inflammation has been investigated in vitro. The alteration of steady state PON1 mRNA in HepG2 cells by interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha), was investigated relative to acute-phase serum amyloid A (A-SAA) mRNA. PON1 mRNA expression by HepG2 cells was decreased within three hours of stimulation by IL-1beta or TNF-alpha. Relative to PON1 mRNA expression, the pattern of steady state A-SAA mRNA expression was altered reciprocally and inversely by IL-1beta. These findings suggested that the decrease in serum PON activity after abdominal surgery in our previous clinical study may be ascribed to a decrease in steady state PON1 mRNA expression by liver with proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408678     DOI: 10.3109/13506120209114817

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  21 in total

1.  Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

2.  Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.

Authors:  A M Gómez-Uriz; E Goyenechea; J Campión; A de Arce; M T Martinez; B Puchau; F I Milagro; I Abete; J A Martínez; A Lopez de Munain
Journal:  J Physiol Biochem       Date:  2014-02-07       Impact factor: 4.158

3.  Paraoxonase and arylesterase levels in rheumatoid arthritis.

Authors:  A Isik; S S Koca; B Ustundag; H Celik; A Yildirim
Journal:  Clin Rheumatol       Date:  2006-04-27       Impact factor: 2.980

4.  The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats.

Authors:  Rita S Strakovsky; Xiyuan Zhang; Dan Zhou; Yuan-Xiang Pan
Journal:  J Nutr Biochem       Date:  2013-11-06       Impact factor: 6.048

5.  A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever.

Authors:  Zeliha Kocak Tufan; Imran Hasanoglu; Servet Kolgelier; Murat Alisik; Merve Ergin; Gul Ruhsar Yilmaz; Mehmet A Tasyaran; Ozcan Erel; Rahmet Guner
Journal:  Redox Rep       Date:  2016-05-09       Impact factor: 4.412

6.  Hormonal and chemical regulation of paraoxonases in mice.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2012-05-31       Impact factor: 4.030

7.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

8.  A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity.

Authors:  Syed Ahmad; Jade J Carter; John E Scott
Journal:  Anal Biochem       Date:  2010-01-21       Impact factor: 3.365

Review 9.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

Review 10.  Non-alcoholic fatty liver disease and the metabolic syndrome: an update.

Authors:  R Scott Rector; John P Thyfault; Yongzhong Wei; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.